EUVIMEDOtkrijte EUVIMED
Crossref

Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation

Mustafa Merter, Ugur Sahin iD, Osman İlhan, Meral Beksac

Journal of Clinical Apheresis · 2023

DOI: 10.1002/jca.22079 ↗

At a glance

Journal article in Journal of Clinical Apheresis, 2023. Written by Mustafa Merter and 3 co-authors. Institution: Hematology Department, School of Medicine, Firat University, Elazıg, Turkey. Major MEDLINE topics: Hematopoietic Stem Cell Transplantation. Cited 5 times so far (Crossref); 50 references.

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Background

Adequate stem cell collection is essential for successful stem cell transplantation. Heparin enhances stem cell mobilization by competing with heparin sulfate proteoglycans. Heparin is also used as an anticoagulant before leukapheresis. Here, we evaluated the effects of heparin on stem cell mobilization in patients who underwent autologous stem cell transplantation (ASCT).

Methods

We evaluated patients who underwent ASCT. Patients were divided into two groups: those who received heparin plus citrate (heparinized patients) and those who received citrate only (nonheparinized patients) for anticoagulation. Univariate and multivariate analyses were also performed. The collection efficiency 2 (CE2) for CD34+ cells was calculated and compared between heparinized and nonheparinized patients.

Results

This study included 1017 patients. There were 478 (47%) heparinized and 539 (53%) nonheparinized patients. The number of collected CD34+ cells was significantly higher in heparinized patients ( P < .00001). The multivariate analyses showed that using heparin was an independent positive factor for collected CD34+ cells (adj‐ R 2 = 0.744; F = 369.331, P < .00001). CE2 was significantly higher in heparinized patients than in nonheparinized patients (66.8% vs 52.1%; P < .00001). The rate of collecting at least 2 × 10 6 /kg CD34+ cells was 3.3 times higher for heparinized patients in poor mobilizers ( P < .00001). Heparinized patients had significantly higher total nucleated and mononuclear cell counts ( P < .00001 and

Subjects

MeSH terms (MEDLINE)

Hematopoietic Stem Cell TransplantationHumansTransplantation, AutologousHematopoietic Stem Cell MobilizationHeparinLeukapheresisCitratesStem Cell TransplantationAntigens, CD34Granulocyte Colony-Stimulating Factor

Author keywords

CE2MNCTNCheparinstem cell mobilization

Substances

HeparinCitratesAntigens, CD34Granulocyte Colony-Stimulating Factor

Authors and institutions

  • Hematology Department, School of Medicine, Firat University, Elazıg, Turkey.
  • Hematology Department, School of Medicine, Ankara University, Ankara, Turkey.

ORCID profiles: Ugur Sahin

Cite

APA

Merter, M., Sahin, U., İlhan, O., & Beksac, M. (2023). Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.22079

Vancouver

Merter M, Sahin U, İlhan O, Beksac M. Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation. Journal of Clinical Apheresis. 2023. doi:10.1002/jca.22079

BibTeX
@article{Merter2023,
  author = {Merter, Mustafa and Sahin, Ugur and İlhan, Osman and Beksac, Meral},
  title = {Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation},
  journal = {Journal of Clinical Apheresis},
  year = {2023},
  doi = {10.1002/jca.22079}
}
Start for free →